nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—CASP9—mammary gland—sarcoma	0.0119	0.0372	CbGeAlD
Hydroxocobalamin—CUBN—myometrium—sarcoma	0.0102	0.0319	CbGeAlD
Hydroxocobalamin—MUT—mammary gland—sarcoma	0.00913	0.0286	CbGeAlD
Hydroxocobalamin—MMAA—hematopoietic system—sarcoma	0.00827	0.0259	CbGeAlD
Hydroxocobalamin—TCN2—myometrium—sarcoma	0.00824	0.0258	CbGeAlD
Hydroxocobalamin—TCN1—hematopoietic system—sarcoma	0.00787	0.0246	CbGeAlD
Hydroxocobalamin—MMAB—hematopoietic system—sarcoma	0.00776	0.0243	CbGeAlD
Hydroxocobalamin—TCN2—seminal vesicle—sarcoma	0.00744	0.0233	CbGeAlD
Hydroxocobalamin—CASP9—hematopoietic system—sarcoma	0.00725	0.0227	CbGeAlD
Hydroxocobalamin—MTR—mammary gland—sarcoma	0.00715	0.0224	CbGeAlD
Hydroxocobalamin—TCN2—hematopoietic system—sarcoma	0.00707	0.0221	CbGeAlD
Hydroxocobalamin—TCN2—connective tissue—sarcoma	0.00681	0.0213	CbGeAlD
Hydroxocobalamin—MMACHC—liver—sarcoma	0.00654	0.0205	CbGeAlD
Hydroxocobalamin—MUT—myometrium—sarcoma	0.00648	0.0203	CbGeAlD
Hydroxocobalamin—MUT—seminal vesicle—sarcoma	0.00585	0.0183	CbGeAlD
Hydroxocobalamin—MTRR—myometrium—sarcoma	0.00582	0.0182	CbGeAlD
Hydroxocobalamin—AMN—testis—sarcoma	0.00569	0.0178	CbGeAlD
Hydroxocobalamin—MUT—hematopoietic system—sarcoma	0.00556	0.0174	CbGeAlD
Hydroxocobalamin—AMN—liver—sarcoma	0.00538	0.0168	CbGeAlD
Hydroxocobalamin—MUT—connective tissue—sarcoma	0.00535	0.0168	CbGeAlD
Hydroxocobalamin—MTRR—seminal vesicle—sarcoma	0.00526	0.0165	CbGeAlD
Hydroxocobalamin—CASP9—lymphoid tissue—sarcoma	0.0051	0.016	CbGeAlD
Hydroxocobalamin—MTR—myometrium—sarcoma	0.00508	0.0159	CbGeAlD
Hydroxocobalamin—TCN1—bone marrow—sarcoma	0.00505	0.0158	CbGeAlD
Hydroxocobalamin—MTRR—hematopoietic system—sarcoma	0.005	0.0156	CbGeAlD
Hydroxocobalamin—TCN2—lymphoid tissue—sarcoma	0.00498	0.0156	CbGeAlD
Hydroxocobalamin—MTRR—connective tissue—sarcoma	0.00481	0.0151	CbGeAlD
Hydroxocobalamin—CUBN—testis—sarcoma	0.00479	0.015	CbGeAlD
Hydroxocobalamin—TCN2—tendon—sarcoma	0.00468	0.0147	CbGeAlD
Hydroxocobalamin—MTR—seminal vesicle—sarcoma	0.00459	0.0144	CbGeAlD
Hydroxocobalamin—MMAA—testis—sarcoma	0.00453	0.0142	CbGeAlD
Hydroxocobalamin—MTR—hematopoietic system—sarcoma	0.00436	0.0136	CbGeAlD
Hydroxocobalamin—MMAA—liver—sarcoma	0.00428	0.0134	CbGeAlD
Hydroxocobalamin—MMAB—testis—sarcoma	0.00425	0.0133	CbGeAlD
Hydroxocobalamin—MUT—cardiac atrium—sarcoma	0.00422	0.0132	CbGeAlD
Hydroxocobalamin—MUT—uterus—sarcoma	0.0042	0.0131	CbGeAlD
Hydroxocobalamin—MTR—connective tissue—sarcoma	0.0042	0.0131	CbGeAlD
Hydroxocobalamin—AMN—lymph node—sarcoma	0.00413	0.0129	CbGeAlD
Hydroxocobalamin—MMAB—liver—sarcoma	0.00402	0.0126	CbGeAlD
Hydroxocobalamin—CASP9—testis—sarcoma	0.00397	0.0124	CbGeAlD
Hydroxocobalamin—TCN2—testis—sarcoma	0.00388	0.0121	CbGeAlD
Hydroxocobalamin—MTRR—cardiac atrium—sarcoma	0.00379	0.0119	CbGeAlD
Hydroxocobalamin—MTRR—uterus—sarcoma	0.00377	0.0118	CbGeAlD
Hydroxocobalamin—CASP9—liver—sarcoma	0.00375	0.0118	CbGeAlD
Hydroxocobalamin—MUT—tendon—sarcoma	0.00368	0.0115	CbGeAlD
Hydroxocobalamin—TCN2—liver—sarcoma	0.00366	0.0115	CbGeAlD
Hydroxocobalamin—MUT—bone marrow—sarcoma	0.00357	0.0112	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—sarcoma	0.00347	0.0109	CbGeAlD
Hydroxocobalamin—MTR—cardiac atrium—sarcoma	0.00331	0.0104	CbGeAlD
Hydroxocobalamin—MTRR—tendon—sarcoma	0.00331	0.0104	CbGeAlD
Hydroxocobalamin—MTR—uterus—sarcoma	0.00329	0.0103	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—sarcoma	0.00328	0.0103	CbGeAlD
Hydroxocobalamin—MTRR—bone marrow—sarcoma	0.0032	0.01	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—sarcoma	0.00308	0.00964	CbGeAlD
Hydroxocobalamin—MUT—testis—sarcoma	0.00305	0.00954	CbGeAlD
Hydroxocobalamin—MTR—tendon—sarcoma	0.00288	0.00903	CbGeAlD
Hydroxocobalamin—MUT—liver—sarcoma	0.00288	0.00902	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—sarcoma	0.00288	0.00901	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—sarcoma	0.00281	0.00879	CbGeAlD
Hydroxocobalamin—MTR—bone marrow—sarcoma	0.00279	0.00875	CbGeAlD
Hydroxocobalamin—MTRR—testis—sarcoma	0.00274	0.00857	CbGeAlD
Hydroxocobalamin—MTRR—liver—sarcoma	0.00259	0.0081	CbGeAlD
Hydroxocobalamin—MTR—testis—sarcoma	0.00239	0.00748	CbGeAlD
Hydroxocobalamin—Venous thrombosis—Doxorubicin—sarcoma	0.00233	0.00741	CcSEcCtD
Hydroxocobalamin—MTR—liver—sarcoma	0.00226	0.00707	CbGeAlD
Hydroxocobalamin—MUT—lymph node—sarcoma	0.00221	0.00692	CbGeAlD
Hydroxocobalamin—Hyponatraemia—Vincristine—sarcoma	0.00218	0.00694	CcSEcCtD
Hydroxocobalamin—Folliculitis—Epirubicin—sarcoma	0.00216	0.00688	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Mitoxantrone—sarcoma	0.00212	0.00676	CcSEcCtD
Hydroxocobalamin—Dysphagia—Dactinomycin—sarcoma	0.0021	0.00669	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Vincristine—sarcoma	0.00207	0.00657	CcSEcCtD
Hydroxocobalamin—Phlebitis—Etoposide—sarcoma	0.00204	0.0065	CcSEcCtD
Hydroxocobalamin—Redness—Epirubicin—sarcoma	0.00201	0.0064	CcSEcCtD
Hydroxocobalamin—Folliculitis—Doxorubicin—sarcoma	0.002	0.00636	CcSEcCtD
Hydroxocobalamin—Swelling—Etoposide—sarcoma	0.00199	0.00635	CcSEcCtD
Hydroxocobalamin—MTRR—lymph node—sarcoma	0.00199	0.00621	CbGeAlD
Hydroxocobalamin—Cardiac failure congestive—Etoposide—sarcoma	0.00194	0.00617	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Mitoxantrone—sarcoma	0.00193	0.00613	CcSEcCtD
Hydroxocobalamin—Lung disorder—Epirubicin—sarcoma	0.00192	0.00611	CcSEcCtD
Hydroxocobalamin—Thrombosis—Epirubicin—sarcoma	0.00192	0.00611	CcSEcCtD
Hydroxocobalamin—Redness—Doxorubicin—sarcoma	0.00186	0.00593	CcSEcCtD
Hydroxocobalamin—Lung disorder—Doxorubicin—sarcoma	0.00178	0.00565	CcSEcCtD
Hydroxocobalamin—Thrombosis—Doxorubicin—sarcoma	0.00178	0.00565	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Epirubicin—sarcoma	0.00177	0.00565	CcSEcCtD
Hydroxocobalamin—MTR—lymph node—sarcoma	0.00173	0.00542	CbGeAlD
Hydroxocobalamin—Feeling hot—Epirubicin—sarcoma	0.00173	0.00551	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Thiotepa—sarcoma	0.00167	0.00532	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Etoposide—sarcoma	0.00167	0.00532	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Thiotepa—sarcoma	0.00166	0.00529	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Doxorubicin—sarcoma	0.00164	0.00522	CcSEcCtD
Hydroxocobalamin—Feeling hot—Doxorubicin—sarcoma	0.0016	0.0051	CcSEcCtD
Hydroxocobalamin—Eye disorder—Thiotepa—sarcoma	0.00158	0.00504	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Thiotepa—sarcoma	0.00157	0.005	CcSEcCtD
Hydroxocobalamin—Extravasation—Epirubicin—sarcoma	0.00156	0.00496	CcSEcCtD
Hydroxocobalamin—Angiopathy—Thiotepa—sarcoma	0.00154	0.00489	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Thiotepa—sarcoma	0.00153	0.00487	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Thiotepa—sarcoma	0.00153	0.00486	CcSEcCtD
Hydroxocobalamin—Dysphagia—Etoposide—sarcoma	0.00152	0.00484	CcSEcCtD
Hydroxocobalamin—Chills—Thiotepa—sarcoma	0.00152	0.00484	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Thiotepa—sarcoma	0.00151	0.00482	CcSEcCtD
Hydroxocobalamin—Chills—Dactinomycin—sarcoma	0.00151	0.0048	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Epirubicin—sarcoma	0.0015	0.00479	CcSEcCtD
Hydroxocobalamin—Mental disorder—Thiotepa—sarcoma	0.00148	0.00472	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Vincristine—sarcoma	0.00148	0.00472	CcSEcCtD
Hydroxocobalamin—Erythema—Thiotepa—sarcoma	0.00148	0.00469	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Vincristine—sarcoma	0.00147	0.00469	CcSEcCtD
Hydroxocobalamin—Erythema—Dactinomycin—sarcoma	0.00146	0.00466	CcSEcCtD
Hydroxocobalamin—Extravasation—Doxorubicin—sarcoma	0.00144	0.00458	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Vincristine—sarcoma	0.00139	0.00444	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Doxorubicin—sarcoma	0.00139	0.00443	CcSEcCtD
Hydroxocobalamin—Angiopathy—Vincristine—sarcoma	0.00136	0.00434	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Dactinomycin—sarcoma	0.00136	0.00432	CcSEcCtD
Hydroxocobalamin—Agitation—Thiotepa—sarcoma	0.00136	0.00431	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Vincristine—sarcoma	0.00135	0.00431	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Epirubicin—sarcoma	0.00135	0.0043	CcSEcCtD
Hydroxocobalamin—Malaise—Dactinomycin—sarcoma	0.00132	0.0042	CcSEcCtD
Hydroxocobalamin—Mental disorder—Vincristine—sarcoma	0.00132	0.00419	CcSEcCtD
Hydroxocobalamin—Chills—Mitoxantrone—sarcoma	0.00131	0.00418	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Mitoxantrone—sarcoma	0.00131	0.00416	CcSEcCtD
Hydroxocobalamin—Erythema—Mitoxantrone—sarcoma	0.00127	0.00405	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Doxorubicin—sarcoma	0.00125	0.00398	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00125	0.00397	CcSEcCtD
Hydroxocobalamin—Discomfort—Dactinomycin—sarcoma	0.00123	0.00392	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Epirubicin—sarcoma	0.00121	0.00385	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Etoposide—sarcoma	0.0012	0.00382	CcSEcCtD
Hydroxocobalamin—Agitation—Vincristine—sarcoma	0.0012	0.00382	CcSEcCtD
Hydroxocobalamin—Infection—Thiotepa—sarcoma	0.0012	0.00381	CcSEcCtD
Hydroxocobalamin—Oedema—Dactinomycin—sarcoma	0.0012	0.0038	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Etoposide—sarcoma	0.00119	0.0038	CcSEcCtD
Hydroxocobalamin—Infection—Dactinomycin—sarcoma	0.00119	0.00378	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Mitoxantrone—sarcoma	0.00118	0.00376	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Thiotepa—sarcoma	0.00118	0.00376	CcSEcCtD
Hydroxocobalamin—Tachycardia—Thiotepa—sarcoma	0.00118	0.00374	CcSEcCtD
Hydroxocobalamin—Skin disorder—Thiotepa—sarcoma	0.00117	0.00372	CcSEcCtD
Hydroxocobalamin—Malaise—Mitoxantrone—sarcoma	0.00115	0.00366	CcSEcCtD
Hydroxocobalamin—Phlebitis—Epirubicin—sarcoma	0.00115	0.00364	CcSEcCtD
Hydroxocobalamin—Eye disorder—Etoposide—sarcoma	0.00114	0.00362	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Etoposide—sarcoma	0.00113	0.00359	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—sarcoma	0.00112	0.00356	CcSEcCtD
Hydroxocobalamin—Angiopathy—Etoposide—sarcoma	0.0011	0.00351	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Etoposide—sarcoma	0.0011	0.0035	CcSEcCtD
Hydroxocobalamin—Eczema—Epirubicin—sarcoma	0.0011	0.00349	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Etoposide—sarcoma	0.0011	0.00349	CcSEcCtD
Hydroxocobalamin—Chills—Etoposide—sarcoma	0.00109	0.00348	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Epirubicin—sarcoma	0.00109	0.00346	CcSEcCtD
Hydroxocobalamin—Chest pain—Mitoxantrone—sarcoma	0.00108	0.00345	CcSEcCtD
Hydroxocobalamin—Discomfort—Mitoxantrone—sarcoma	0.00107	0.00341	CcSEcCtD
Hydroxocobalamin—Oedema—Vincristine—sarcoma	0.00107	0.0034	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Vincristine—sarcoma	0.00107	0.0034	CcSEcCtD
Hydroxocobalamin—Infection—Vincristine—sarcoma	0.00106	0.00337	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Thiotepa—sarcoma	0.00106	0.00337	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—sarcoma	0.00106	0.00337	CcSEcCtD
Hydroxocobalamin—Hot flush—Epirubicin—sarcoma	0.00105	0.00335	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Vincristine—sarcoma	0.00105	0.00333	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Epirubicin—sarcoma	0.00105	0.00333	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Mitoxantrone—sarcoma	0.00104	0.00331	CcSEcCtD
Hydroxocobalamin—Oedema—Mitoxantrone—sarcoma	0.00104	0.00331	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Thiotepa—sarcoma	0.00104	0.00331	CcSEcCtD
Hydroxocobalamin—Infection—Mitoxantrone—sarcoma	0.00103	0.00329	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Epirubicin—sarcoma	0.00103	0.00328	CcSEcCtD
Hydroxocobalamin—Pain—Thiotepa—sarcoma	0.00103	0.00328	CcSEcCtD
Hydroxocobalamin—Pain—Dactinomycin—sarcoma	0.00102	0.00325	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—sarcoma	0.00102	0.00323	CcSEcCtD
Hydroxocobalamin—Tachycardia—Mitoxantrone—sarcoma	0.00101	0.00323	CcSEcCtD
Hydroxocobalamin—Skin disorder—Mitoxantrone—sarcoma	0.00101	0.00321	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—sarcoma	0.00101	0.0032	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Thiotepa—sarcoma	0.000992	0.00316	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Epirubicin—sarcoma	0.00099	0.00315	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Dactinomycin—sarcoma	0.000985	0.00313	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Etoposide—sarcoma	0.000983	0.00313	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—sarcoma	0.000976	0.0031	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—sarcoma	0.000967	0.00308	CcSEcCtD
Hydroxocobalamin—Urticaria—Thiotepa—sarcoma	0.000957	0.00304	CcSEcCtD
Hydroxocobalamin—Malaise—Etoposide—sarcoma	0.000956	0.00304	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—sarcoma	0.000955	0.00304	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Thiotepa—sarcoma	0.000952	0.00303	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Dactinomycin—sarcoma	0.000945	0.00301	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Epirubicin—sarcoma	0.000938	0.00298	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Mitoxantrone—sarcoma	0.000927	0.00295	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Vincristine—sarcoma	0.000922	0.00293	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—sarcoma	0.000916	0.00292	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Mitoxantrone—sarcoma	0.000915	0.00291	CcSEcCtD
Hydroxocobalamin—Pain—Vincristine—sarcoma	0.000913	0.0029	CcSEcCtD
Hydroxocobalamin—Chest pain—Etoposide—sarcoma	0.000902	0.00287	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Epirubicin—sarcoma	0.000898	0.00286	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000896	0.00285	CcSEcCtD
Hydroxocobalamin—Discomfort—Etoposide—sarcoma	0.000891	0.00284	CcSEcCtD
Hydroxocobalamin—Pain—Mitoxantrone—sarcoma	0.000889	0.00283	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Thiotepa—sarcoma	0.000887	0.00282	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Dactinomycin—sarcoma	0.00088	0.0028	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—sarcoma	0.000868	0.00276	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Etoposide—sarcoma	0.000865	0.00275	CcSEcCtD
Hydroxocobalamin—Infection—Etoposide—sarcoma	0.000859	0.00273	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Mitoxantrone—sarcoma	0.000857	0.00273	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—sarcoma	0.000853	0.00271	CcSEcCtD
Hydroxocobalamin—Pruritus—Thiotepa—sarcoma	0.000852	0.00271	CcSEcCtD
Hydroxocobalamin—Tachycardia—Etoposide—sarcoma	0.000844	0.00269	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Vincristine—sarcoma	0.000844	0.00269	CcSEcCtD
Hydroxocobalamin—Skin disorder—Etoposide—sarcoma	0.00084	0.00267	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—sarcoma	0.000831	0.00264	CcSEcCtD
Hydroxocobalamin—Urticaria—Mitoxantrone—sarcoma	0.000826	0.00263	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Thiotepa—sarcoma	0.000824	0.00262	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Mitoxantrone—sarcoma	0.000822	0.00262	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Dactinomycin—sarcoma	0.000818	0.0026	CcSEcCtD
Hydroxocobalamin—Dizziness—Thiotepa—sarcoma	0.000796	0.00253	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—sarcoma	0.000789	0.00251	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Vincristine—sarcoma	0.000787	0.0025	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Etoposide—sarcoma	0.000771	0.00245	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Mitoxantrone—sarcoma	0.000766	0.00244	CcSEcCtD
Hydroxocobalamin—Rash—Thiotepa—sarcoma	0.000759	0.00242	CcSEcCtD
Hydroxocobalamin—Dermatitis—Thiotepa—sarcoma	0.000759	0.00241	CcSEcCtD
Hydroxocobalamin—Headache—Thiotepa—sarcoma	0.000754	0.0024	CcSEcCtD
Hydroxocobalamin—Rash—Dactinomycin—sarcoma	0.000754	0.0024	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Etoposide—sarcoma	0.000747	0.00238	CcSEcCtD
Hydroxocobalamin—Pain—Etoposide—sarcoma	0.00074	0.00235	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vincristine—sarcoma	0.000731	0.00232	CcSEcCtD
Hydroxocobalamin—Nausea—Thiotepa—sarcoma	0.000715	0.00228	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Etoposide—sarcoma	0.000713	0.00227	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Mitoxantrone—sarcoma	0.000711	0.00226	CcSEcCtD
Hydroxocobalamin—Nausea—Dactinomycin—sarcoma	0.00071	0.00226	CcSEcCtD
Hydroxocobalamin—Dizziness—Vincristine—sarcoma	0.000706	0.00225	CcSEcCtD
Hydroxocobalamin—Urticaria—Etoposide—sarcoma	0.000687	0.00219	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Etoposide—sarcoma	0.000684	0.00218	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—sarcoma	0.000674	0.00214	CcSEcCtD
Hydroxocobalamin—Rash—Vincristine—sarcoma	0.000673	0.00214	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vincristine—sarcoma	0.000673	0.00214	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—sarcoma	0.000672	0.00214	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—sarcoma	0.000669	0.00213	CcSEcCtD
Hydroxocobalamin—Headache—Vincristine—sarcoma	0.000669	0.00213	CcSEcCtD
Hydroxocobalamin—Rash—Mitoxantrone—sarcoma	0.000656	0.00209	CcSEcCtD
Hydroxocobalamin—Dermatitis—Mitoxantrone—sarcoma	0.000655	0.00208	CcSEcCtD
Hydroxocobalamin—Headache—Mitoxantrone—sarcoma	0.000651	0.00207	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—sarcoma	0.000638	0.00203	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Etoposide—sarcoma	0.000637	0.00203	CcSEcCtD
Hydroxocobalamin—Nausea—Vincristine—sarcoma	0.000634	0.00202	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—sarcoma	0.000633	0.00201	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—sarcoma	0.000624	0.00198	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—sarcoma	0.000622	0.00198	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—sarcoma	0.000619	0.00197	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—sarcoma	0.000619	0.00197	CcSEcCtD
Hydroxocobalamin—Nausea—Mitoxantrone—sarcoma	0.000618	0.00196	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—sarcoma	0.000616	0.00196	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—sarcoma	0.000615	0.00196	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—sarcoma	0.000612	0.00195	CcSEcCtD
Hydroxocobalamin—Pruritus—Etoposide—sarcoma	0.000612	0.00195	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—sarcoma	0.00061	0.00194	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—sarcoma	0.000598	0.0019	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—sarcoma	0.000594	0.00189	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Etoposide—sarcoma	0.000592	0.00188	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—sarcoma	0.00059	0.00188	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—sarcoma	0.000586	0.00186	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—sarcoma	0.000573	0.00182	CcSEcCtD
Hydroxocobalamin—Dizziness—Etoposide—sarcoma	0.000572	0.00182	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—sarcoma	0.00057	0.00181	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—sarcoma	0.000569	0.00181	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—sarcoma	0.000567	0.0018	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—sarcoma	0.000564	0.00179	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—sarcoma	0.000553	0.00176	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—sarcoma	0.000551	0.00175	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—sarcoma	0.00055	0.00175	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—sarcoma	0.000546	0.00174	CcSEcCtD
Hydroxocobalamin—Rash—Etoposide—sarcoma	0.000545	0.00173	CcSEcCtD
Hydroxocobalamin—Dermatitis—Etoposide—sarcoma	0.000545	0.00173	CcSEcCtD
Hydroxocobalamin—Headache—Etoposide—sarcoma	0.000542	0.00172	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—sarcoma	0.000536	0.0017	CcSEcCtD
Hydroxocobalamin—Nausea—Etoposide—sarcoma	0.000514	0.00163	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—sarcoma	0.00051	0.00162	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—sarcoma	0.000506	0.00161	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—sarcoma	0.000505	0.00161	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000502	0.0016	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—sarcoma	0.0005	0.00159	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—sarcoma	0.000496	0.00158	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—sarcoma	0.000485	0.00154	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—sarcoma	0.000485	0.00154	CcSEcCtD
Hydroxocobalamin—Infection—Epirubicin—sarcoma	0.000482	0.00153	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Epirubicin—sarcoma	0.000475	0.00151	CcSEcCtD
Hydroxocobalamin—Tachycardia—Epirubicin—sarcoma	0.000473	0.00151	CcSEcCtD
Hydroxocobalamin—Skin disorder—Epirubicin—sarcoma	0.000471	0.0015	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—sarcoma	0.000468	0.00149	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000465	0.00148	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—sarcoma	0.000462	0.00147	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—sarcoma	0.000449	0.00143	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—sarcoma	0.000449	0.00143	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—sarcoma	0.000446	0.00142	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—sarcoma	0.00044	0.0014	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—sarcoma	0.000438	0.00139	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—sarcoma	0.000436	0.00139	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Epirubicin—sarcoma	0.000432	0.00138	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—sarcoma	0.000427	0.00136	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000419	0.00133	CcSEcCtD
Hydroxocobalamin—Pain—Epirubicin—sarcoma	0.000415	0.00132	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Doxorubicin—sarcoma	0.0004	0.00127	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—sarcoma	0.0004	0.00127	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—sarcoma	0.000395	0.00126	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000387	0.00123	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—sarcoma	0.000385	0.00123	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—sarcoma	0.000384	0.00122	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—sarcoma	0.000383	0.00122	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—sarcoma	0.00037	0.00118	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Epirubicin—sarcoma	0.000357	0.00114	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—sarcoma	0.000356	0.00113	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—sarcoma	0.000355	0.00113	CcSEcCtD
Hydroxocobalamin—Pruritus—Epirubicin—sarcoma	0.000343	0.00109	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Epirubicin—sarcoma	0.000332	0.00106	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—sarcoma	0.000331	0.00105	CcSEcCtD
Hydroxocobalamin—Dizziness—Epirubicin—sarcoma	0.000321	0.00102	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—sarcoma	0.000317	0.00101	CcSEcCtD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—EGFR—sarcoma	0.000316	0.000864	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—KRAS—sarcoma	0.000309	0.000845	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—NRAS—sarcoma	0.000308	0.000842	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—KRAS—sarcoma	0.000308	0.00084	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Doxorubicin—sarcoma	0.000307	0.000976	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—FOXO1—sarcoma	0.000307	0.000838	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—SRC—sarcoma	0.000307	0.000837	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PDGFRB—sarcoma	0.000306	0.000836	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—KRAS—sarcoma	0.000306	0.000836	CbGpPWpGaD
Hydroxocobalamin—Rash—Epirubicin—sarcoma	0.000306	0.000973	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—sarcoma	0.000305	0.000972	CcSEcCtD
Hydroxocobalamin—MMAB—Disease—CREB1—sarcoma	0.000305	0.000833	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CREB1—sarcoma	0.000305	0.000833	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—KRAS—sarcoma	0.000305	0.000832	CbGpPWpGaD
Hydroxocobalamin—Headache—Epirubicin—sarcoma	0.000304	0.000966	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 interactions—EGFR—sarcoma	0.000303	0.000829	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—EGFR—sarcoma	0.000303	0.000829	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—EGFR—sarcoma	0.000303	0.000829	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—MDM2—sarcoma	0.000303	0.000826	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PDGFRA—sarcoma	0.000301	0.000823	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—EGFR—sarcoma	0.000301	0.000821	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—KRAS—sarcoma	0.0003	0.00082	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—KRAS—sarcoma	0.000299	0.000816	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—EGFR—sarcoma	0.000298	0.000814	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KIT—sarcoma	0.000298	0.000814	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PLCG1—sarcoma	0.000297	0.000812	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—EGFR—sarcoma	0.000297	0.000811	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Doxorubicin—sarcoma	0.000297	0.000944	CcSEcCtD
Hydroxocobalamin—CASP9—Disease—NPM1—sarcoma	0.000296	0.00081	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—NRAS—sarcoma	0.000295	0.000806	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—HRAS—sarcoma	0.000292	0.000798	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000292	0.000797	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PLCG1—sarcoma	0.000289	0.00079	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000289	0.00079	CbGpPWpGaD
Hydroxocobalamin—Nausea—Epirubicin—sarcoma	0.000288	0.000916	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—FOXO1—sarcoma	0.000288	0.000785	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PDGFRB—sarcoma	0.000287	0.000784	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—KRAS—sarcoma	0.000287	0.000783	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—KRAS—sarcoma	0.000287	0.000783	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—KRAS—sarcoma	0.000287	0.000783	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ENO2—sarcoma	0.000286	0.00078	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000286	0.00078	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—KRAS—sarcoma	0.000284	0.000776	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—HBA1—sarcoma	0.000284	0.000775	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CREB1—sarcoma	0.000284	0.000774	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—sarcoma	0.000283	0.000774	CbGpPWpGaD
Hydroxocobalamin—Rash—Doxorubicin—sarcoma	0.000283	0.0009	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—sarcoma	0.000283	0.000899	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—PDGFRA—sarcoma	0.000283	0.000772	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—KRAS—sarcoma	0.000282	0.000769	CbGpPWpGaD
Hydroxocobalamin—Headache—Doxorubicin—sarcoma	0.000281	0.000894	CcSEcCtD
Hydroxocobalamin—CASP9—B Cell Activation—EGFR—sarcoma	0.000281	0.000767	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—KRAS—sarcoma	0.00028	0.000766	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—HRAS—sarcoma	0.00028	0.000764	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CXCR4—sarcoma	0.000278	0.000759	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—FOXO1—sarcoma	0.000276	0.000754	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MDM2—sarcoma	0.000276	0.000754	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PDGFRB—sarcoma	0.000276	0.000753	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—HRAS—sarcoma	0.000275	0.000752	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PDGFRA—sarcoma	0.000271	0.000741	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.00027	0.000737	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—EGFR—sarcoma	0.000269	0.000734	CbGpPWpGaD
Hydroxocobalamin—Nausea—Doxorubicin—sarcoma	0.000266	0.000848	CcSEcCtD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TP53—sarcoma	0.000266	0.000726	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KIT—sarcoma	0.000266	0.000725	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KIT—sarcoma	0.000266	0.000725	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—KRAS—sarcoma	0.000265	0.000725	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—HRAS—sarcoma	0.000263	0.000718	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—HRAS—sarcoma	0.000262	0.000714	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—HRAS—sarcoma	0.00026	0.000711	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—HRAS—sarcoma	0.000259	0.000707	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ENO2—sarcoma	0.000257	0.000701	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	0.000255	0.000697	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	0.000254	0.000693	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KIT—sarcoma	0.000253	0.000692	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CREB1—sarcoma	0.000253	0.00069	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CREB1—sarcoma	0.000253	0.00069	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MDM2—sarcoma	0.000252	0.000689	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MDM2—sarcoma	0.000252	0.000689	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—FOXO1—sarcoma	0.000252	0.000688	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PDGFRB—sarcoma	0.000251	0.000687	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PDGFRA—sarcoma	0.000248	0.000676	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—HRAS—sarcoma	0.000244	0.000665	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—HRAS—sarcoma	0.000244	0.000665	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	0.000244	0.000665	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PLCG1—sarcoma	0.000242	0.000662	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—HRAS—sarcoma	0.000242	0.00066	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTPRC—sarcoma	0.000241	0.000659	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CREB1—sarcoma	0.000241	0.000658	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.00024	0.000655	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—HRAS—sarcoma	0.000239	0.000654	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—HRAS—sarcoma	0.000238	0.000651	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CTNNB1—sarcoma	0.000238	0.00065	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PLCG1—sarcoma	0.000236	0.000645	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—SRC—sarcoma	0.000236	0.000644	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MDM2—sarcoma	0.000235	0.000641	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KIT—sarcoma	0.000234	0.000638	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TLE1—sarcoma	0.00023	0.000629	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—NRAS—sarcoma	0.000227	0.00062	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—HRAS—sarcoma	0.000226	0.000616	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ATF1—sarcoma	0.000224	0.000612	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CREB1—sarcoma	0.000223	0.000608	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KIT—sarcoma	0.000219	0.000598	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PLCG1—sarcoma	0.000218	0.000595	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CTNNB1—sarcoma	0.000218	0.000594	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CTNNB1—sarcoma	0.000218	0.000594	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	0.000216	0.000589	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—SRC—sarcoma	0.000215	0.000588	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KIT—sarcoma	0.00021	0.000575	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CXCR4—sarcoma	0.000209	0.000572	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MDM2—sarcoma	0.000209	0.000571	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MDM2—sarcoma	0.000209	0.000571	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CREB1—sarcoma	0.000209	0.00057	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—NRAS—sarcoma	0.000207	0.000565	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—EGFR—sarcoma	0.000207	0.000565	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FOXO1—sarcoma	0.000205	0.000561	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PDGFRB—sarcoma	0.000205	0.00056	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CTNNB1—sarcoma	0.000202	0.000553	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PDGFRA—sarcoma	0.000202	0.000551	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CREB1—sarcoma	0.0002	0.000547	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MDM2—sarcoma	0.000199	0.000545	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—SRC—sarcoma	0.000197	0.000537	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—SRC—sarcoma	0.000197	0.000537	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—KRAS—sarcoma	0.000195	0.000533	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFC—sarcoma	0.000194	0.00053	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MYC—sarcoma	0.000193	0.000526	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KIT—sarcoma	0.000192	0.000524	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—NRAS—sarcoma	0.000189	0.000517	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—NRAS—sarcoma	0.000189	0.000517	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—EGFR—sarcoma	0.000189	0.000515	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MDM2—sarcoma	0.000184	0.000503	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—SRC—sarcoma	0.000183	0.0005	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CREB1—sarcoma	0.000183	0.000499	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CTNNB1—sarcoma	0.00018	0.000493	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CTNNB1—sarcoma	0.00018	0.000493	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—KRAS—sarcoma	0.000178	0.000486	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MYC—sarcoma	0.000176	0.000482	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MYC—sarcoma	0.000176	0.000482	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—NRAS—sarcoma	0.000176	0.000481	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MDM2—sarcoma	0.000173	0.000471	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EGFR—sarcoma	0.000172	0.000471	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EGFR—sarcoma	0.000172	0.000471	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CTNNB1—sarcoma	0.000172	0.00047	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FOXO1—sarcoma	0.000167	0.000457	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PDGFRB—sarcoma	0.000167	0.000457	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—HRAS—sarcoma	0.000166	0.000453	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—MDM2—sarcoma	0.000166	0.000452	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PDGFRA—sarcoma	0.000165	0.000449	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MYC—sarcoma	0.000164	0.000448	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—SRC—sarcoma	0.000163	0.000445	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—SRC—sarcoma	0.000163	0.000445	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KRAS—sarcoma	0.000163	0.000445	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KRAS—sarcoma	0.000163	0.000445	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EGFR—sarcoma	0.00016	0.000438	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CTNNB1—sarcoma	0.000159	0.000434	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NRAS—sarcoma	0.000157	0.000428	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NRAS—sarcoma	0.000157	0.000428	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KIT—sarcoma	0.000156	0.000427	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—SRC—sarcoma	0.000156	0.000425	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FLT1—sarcoma	0.000155	0.000424	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FOXO1—sarcoma	0.000155	0.000422	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PDGFRB—sarcoma	0.000154	0.000422	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PLCG1—sarcoma	0.000153	0.000417	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PDGFRA—sarcoma	0.000152	0.000415	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KRAS—sarcoma	0.000151	0.000414	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HRAS—sarcoma	0.000151	0.000413	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MDM2—sarcoma	0.000151	0.000413	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—JUN—sarcoma	0.00015	0.00041	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NRAS—sarcoma	0.00015	0.000409	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CREB1—sarcoma	0.000149	0.000407	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CTNNB1—sarcoma	0.000149	0.000406	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCR4—sarcoma	0.000147	0.0004	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MYC—sarcoma	0.000146	0.000399	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MYC—sarcoma	0.000146	0.000399	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ATF1—sarcoma	0.000145	0.000396	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—SRC—sarcoma	0.000144	0.000392	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—sarcoma	0.000143	0.00039	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—sarcoma	0.000143	0.00039	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MYC—sarcoma	0.000139	0.000381	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HRAS—sarcoma	0.000138	0.000378	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HRAS—sarcoma	0.000138	0.000378	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NRAS—sarcoma	0.000138	0.000377	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—sarcoma	0.000136	0.000372	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—sarcoma	0.000135	0.000369	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—sarcoma	0.000135	0.000369	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—SRC—sarcoma	0.000135	0.000367	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CTNNB1—sarcoma	0.00013	0.000356	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRAS—sarcoma	0.000129	0.000353	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—SRC—sarcoma	0.000129	0.000353	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—sarcoma	0.000129	0.000352	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—sarcoma	0.000129	0.000352	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—sarcoma	0.000129	0.000351	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KIT—sarcoma	0.000128	0.000348	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—sarcoma	0.000126	0.000344	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRAS—sarcoma	0.000124	0.000339	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MDM2—sarcoma	0.000123	0.000337	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CREB1—sarcoma	0.000121	0.000332	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—sarcoma	0.000119	0.000325	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—sarcoma	0.000118	0.000322	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SRC—sarcoma	0.000118	0.000322	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KIT—sarcoma	0.000118	0.000322	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—sarcoma	0.000115	0.000313	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—sarcoma	0.000115	0.000313	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1R—sarcoma	0.000114	0.000311	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRAS—sarcoma	0.000113	0.00031	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—sarcoma	0.000113	0.000309	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CREB1—sarcoma	0.000112	0.000306	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—sarcoma	0.000111	0.000304	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—sarcoma	0.000109	0.000299	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FOXO1—sarcoma	0.000108	0.000296	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFRB—sarcoma	0.000108	0.000295	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—sarcoma	0.000107	0.000292	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFRA—sarcoma	0.000106	0.000291	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CTNNB1—sarcoma	0.000106	0.00029	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—sarcoma	0.000106	0.000288	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—sarcoma	0.000103	0.000282	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—sarcoma	0.000101	0.000276	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MDM2—sarcoma	0.0001	0.000274	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—sarcoma	9.76e-05	0.000267	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SRC—sarcoma	9.61e-05	0.000262	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—sarcoma	9.47e-05	0.000259	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MDM2—sarcoma	9.28e-05	0.000253	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRAS—sarcoma	9.24e-05	0.000252	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—sarcoma	9.09e-05	0.000248	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2—sarcoma	8.98e-05	0.000245	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KDR—sarcoma	8.96e-05	0.000245	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—JUN—sarcoma	8.74e-05	0.000239	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTNNB1—sarcoma	8.67e-05	0.000237	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—sarcoma	8.61e-05	0.000235	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—sarcoma	8.42e-05	0.00023	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—sarcoma	8.3e-05	0.000227	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KIT—sarcoma	8.25e-05	0.000225	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CTNNB1—sarcoma	8e-05	0.000219	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—sarcoma	7.96e-05	0.000217	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CREB1—sarcoma	7.85e-05	0.000214	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SRC—sarcoma	7.84e-05	0.000214	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRAS—sarcoma	7.54e-05	0.000206	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SRC—sarcoma	7.23e-05	0.000198	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRAS—sarcoma	6.96e-05	0.00019	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—sarcoma	6.87e-05	0.000188	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—sarcoma	6.76e-05	0.000185	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MDM2—sarcoma	6.5e-05	0.000177	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—sarcoma	6.49e-05	0.000177	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—sarcoma	6.48e-05	0.000177	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—sarcoma	6.34e-05	0.000173	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—sarcoma	5.99e-05	0.000164	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2—sarcoma	5.81e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—sarcoma	5.66e-05	0.000155	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JUN—sarcoma	5.65e-05	0.000154	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNB1—sarcoma	5.6e-05	0.000153	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—sarcoma	5.51e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—sarcoma	5.09e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SRC—sarcoma	5.07e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—sarcoma	4.93e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRAS—sarcoma	4.87e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—sarcoma	4.54e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—sarcoma	4.44e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—sarcoma	4.19e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—sarcoma	3.73e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—sarcoma	3.57e-05	9.74e-05	CbGpPWpGaD
